Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
XstFrh3h8Emug9Je